Companies / EchoStar CORP / Activity
Activity — EchoStar CORP
50 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Manson Dean Executive | Exercise | Class A Common Stock | $56.2K | +4K +79.08% | 9,058 <0.01% of shares | low |
| Jun 12, 2026 | Manson Dean Executive | Exercise | Class A Common Stock | $84.2K | +6K +118.62% | 11,058 <0.01% of shares | low |
| Mar 5, 2026 | Manson Dean Executive | Exercise | Class A Common Stock | $107.1K | +8K +318.22% | 10,029 <0.01% of shares | low |
| Jun 4, 2026 | Manson Dean Executive | Exercise | Class A Common Stock | $140.4K | +10K +197.71% | 15,058 <0.01% of shares | low |
| Dec 31, 2025 | Abernathy Kathleen Q Director | Exercise | Class A Common Stock | $161.7K | +2K | 1,754 <0.01% of shares | low |
| Dec 31, 2025 | Ergen Cantey Director | Exercise | Class A Common Stock | $161.7K | +2K +823.47% | 1,967 <0.01% of shares | low |
| Dec 31, 2025 | Abernathy Kathleen Q Director | Other | Class A Common Stock | $161.7K | -1K -84.83% | 266 <0.01% of shares | low |
| Mar 5, 2026 | Manson Dean Executive | Exercise | Class A Common Stock | $196.6K | +14K +583.82% | 16,398 <0.01% of shares | low |
| Jun 5, 2026 | Akhavan Hamid CEO | Exercise | Class A Common Stock | $286.7K | +20K +2.36% | 886,050 0.31% of shares | low |
| Mar 6, 2026 | Akhavan Hamid CEO | Exercise | Class A Common Stock | $286.7K | +20K +3.19% | 660,380 0.23% of shares | low |
| Jun 12, 2026 | Manson Dean Executive | Sell | Class A Common Stock | $521.6K | -4K -44.16% | 5,058 <0.01% of shares | medium |
| Mar 4, 2026 | Swieringa John Executive | Exercise | Class A Common Stock | $581.4K | +35K +13.84% | 288,623 0.10% of shares | low |
| Jun 12, 2026 | Manson Dean Executive | Sell | Class A Common Stock | $782.3K | -6K -54.26% | 5,058 <0.01% of shares | medium |
| Mar 5, 2026 | Manson Dean Executive | Sell | Class A Common Stock | $873.8K | -8K -76.09% | 2,398 <0.01% of shares | medium |
| Jan 2, 2026 | Swieringa John Executive | Other | Class A Common Stock | $893.4K | -8K -2.81% | 275,553 0.09% of shares | low |
| Jun 5, 2026 | Akhavan Hamid CEO | Sell | Class A Common Stock | $909.1K | -8K -0.85% | 878,537 0.30% of shares | medium |
| Jun 4, 2026 | Manson Dean Executive | Sell | Class A Common Stock | $1.20M | -10K -66.41% | 5,058 <0.01% of shares | medium |
| Mar 5, 2026 | Manson Dean Executive | Sell | Class A Common Stock | $1.31M | -11K -69.52% | 4,998 <0.01% of shares | medium |
| Mar 4, 2026 | Swieringa John Executive | Sell | Class A Common Stock | $1.71M | -15K -5.59% | 253,535 0.09% of shares | medium |
| Jun 5, 2026 | Akhavan Hamid CEO | Exercise | Class A Common Stock | $1.72M | +123K +15.54% | 910,706 0.31% of shares | low |
| Mar 6, 2026 | Akhavan Hamid CEO | Exercise | Class A Common Stock | $3.88M | +234K +35.42% | 894,298 0.31% of shares | low |
| Mar 4, 2026 | Swieringa John Executive | Sell | Class A Common Stock | $3.98M | -35K -12.16% | 253,535 0.09% of shares | medium |
| Jun 5, 2026 | Akhavan Hamid CEO | Sell | Class A Common Stock | $5.45M | -45K -4.95% | 865,633 0.30% of shares | medium |
| Mar 6, 2026 | Akhavan Hamid CEO | Sell | Class A Common Stock | $7.63M | -71K -7.94% | 823,293 0.28% of shares | medium |
| Apr 1, 2026 | Abernathy Kathleen Q Director | Grant | Non-Employee Director Stock Option | — | +5K | 5,000 <0.01% of shares | low |
| Jun 12, 2026 | Manson Dean Executive | Exercise | Employee Stock Option (Right to Buy) | — | -6K -15.11% | 33,700 0.01% of shares | low |
| Jun 12, 2026 | Manson Dean Executive | Exercise | Employee Stock Option (Right to Buy) | — | -4K -12.50% | 28,000 <0.01% of shares | low |
| Jun 4, 2026 | Manson Dean Executive | Exercise | Employee Stock Option (Right to Buy) | — | -10K -23.81% | 32,000 0.01% of shares | low |
| Apr 1, 2026 | Ortolf Tom A Director | Grant | Non-Employee Director Stock Option | — | +5K | 5,000 <0.01% of shares | low |
| Jun 5, 2026 | Akhavan Hamid CEO | Exercise | Employee Stock Option (Right to Buy) | — | -20K -33.33% | 40,834 0.01% of shares | low |
| Jun 5, 2026 | Akhavan Hamid CEO | Exercise | Employee Stock Option (Right to Buy) | — | -123K -100.00% | 0 0.00% of shares | low |
| Jun 26, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | +2.3M +3221.25% | 2,388,447 0.82% of shares | low |
| Jun 26, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | -2.3M -13.79% | 14,483,467 4.99% of shares | low |
| Jun 15, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | +4.3M | 4,300,000 1.48% of shares | low |
| Jun 15, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | -4.3M -98.36% | 71,914 0.02% of shares | low |
| May 13, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | +1.9M +77.06% | 4,371,914 1.51% of shares | low |
| May 13, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | -1.9M -7.61% | 23,097,210 7.95% of shares | low |
| May 13, 2026 | Ergen Charles W CEO | Other | Class B Common Stock | — | +2.9M +5.08% | 60,517,502 20.83% of shares | low |
| May 13, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | +381K +18.25% | 2,469,124 0.85% of shares | low |
| May 13, 2026 | Ergen Charles W CEO | Gift | Class B Common Stock | — | -3.3M -100.00% | 0 0.00% of shares | low |
| Apr 1, 2026 | Ergen Cantey Director | Grant | Employee Stock Option (Right to Buy) | — | +5K | 5,000 <0.01% of shares | low |
| Mar 4, 2026 | Swieringa John Executive | Exercise | Employee Stock Option (Right To Buy) | — | -35K -25.00% | 105,264 0.04% of shares | low |
| Mar 6, 2026 | Akhavan Hamid CEO | Exercise | Employee Stock Option (Right to Buy) | — | -234K -50.00% | 233,919 0.08% of shares | low |
| Mar 6, 2026 | Akhavan Hamid CEO | Exercise | Employee Stock Option (Right to Buy) | — | -20K -25.00% | 61,251 0.02% of shares | low |
| Mar 5, 2026 | Manson Dean Executive | Exercise | Employee Stock Option (Right to Buy) | — | -14K -25.00% | 42,000 0.01% of shares | low |
| Mar 5, 2026 | Manson Dean Executive | Exercise | Employee Stock Option (Right to Buy) | — | -8K -16.12% | 39,700 0.01% of shares | low |
| Dec 31, 2025 | Abernathy Kathleen Q Director | Exercise | Non-Employee Director Stock Option | — | -2K -100.00% | 0 0.00% of shares | low |
| Dec 31, 2025 | Akhavan Hamid CEO | Exercise | Restricted Stock Units | — | +263K | 0 0.00% of shares | low |
| Dec 31, 2025 | Akhavan Hamid CEO | Exercise | Class A Common Stock | — | +263K +77.01% | 604,876 0.21% of shares | low |
| Dec 31, 2025 | Ergen Cantey Director | Exercise | Employee Stock Option (Right to Buy) | — | -2K -100.00% | 0 0.00% of shares | low |